Development and characterization of ligand-appended liposomes for multiple drug therapy for pulmonary tuberculosis.

Artificial cells, nanomedicine, and biotechnology (Print)

Volumn 41, Issue 1, 2013, Pages 52-59

  Bhardwaj, Ankur ^a   Kumar, Lalit ^b   Narang, R K ^b   Murthy, R S ^b  

^a ISF COLLEGE OF PHARMACY   (India)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; LIGAND; LIPOSOME; PYRAZINAMIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ANIMAL; ARTICLE; DRUG COMBINATION; DRUG DELIVERY SYSTEM; DRUG EFFECT; HUMAN; LUNG TUBERCULOSIS; METHODOLOGY; MYCOBACTERIUM TUBERCULOSIS; RAT; RAT STRAIN; SYNTHESIS;

ANIMALS; ANTITUBERCULAR AGENTS; DRUG DELIVERY SYSTEMS; DRUG THERAPY, COMBINATION; HUMANS; ISONIAZID; LIGANDS; LIPOSOMES; MYCOBACTERIUM TUBERCULOSIS; PYRAZINAMIDE; RATS; RATS, INBRED STRAINS; RIFAMPIN; TUBERCULOSIS, PULMONARY;

EID: 84875203292     PISSN: None     EISSN: 2169141X     Source Type: None    
DOI: 10.3109/10731199.2012.702316     Document Type: Article

References (0)